Author

A. Penna

Observed names: A Penna, A.B.R.C. Penna

Observed institutions: Pontifícia Universidade Católica do Rio de Janeiro, Ospedale San Paolo

OpenAlex ID: A5112800914

Serum levels of selenium in patients with breast cancer before and after treatment of external beam radiotherapy

2010 · C.A.S. Franca, C.R. Nogueira, et al. · Annals of Oncology · 42

Effectiveness of different therapeutic strategies in preventing diverticulitis recurrence.

2013 · A Tursi, W Elisei, et al. · PubMed · 29

Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study.

2021 · A Tursi, G Mocci, et al. · PubMed · 19

New Insights into the Biological and Clinical Significance of Fecal Calprotectin in Inflammatory Bowel Disease

2006 · L. Amati, M.E. Passeri, et al. · Immunopharmacology and Immunotoxicology · 13

Safety and effectiveness of infliximab for inflammatory bowel diseases in clinical practice.

2010 · A Tursi, W Elisei, et al. · PubMed · 11

Letter: effectiveness of golimumab to induce remission in outpatient ulcerative colitis in Italy

2016 · A. Tursi, N. Della Valle, et al. · Alimentary Pharmacology & Therapeutics · 3

P473 Histological inflammation in ulcerative colitis in deep remission under treatment with infliximab

2014 · A. Tursi, W. Elisei, et al. · Journal of Crohn s and Colitis · 1

Letter: are infliximab and adalimumab similar for C rohn's disease in clinical practice?

2013 · A. Tursi, W. Elisei, et al. · Alimentary Pharmacology & Therapeutics · 1

Crohn’s appendicitis

2010 · A. Tursi, A. Penna · Endoscopy · 1

P583 Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn’s disease: results from a large Italian cohort study

2021 · G Mocci, A Cuomo, et al. · Journal of Crohn s and Colitis

P.11.20: Real-Life Prospective Experience with Adalimumab in Inducing Remission in Ulcerative Colitis in Primary Inflammatory Bowel Diseases Centres

2017 · A. Tursi, L. Allegretta, et al. · Digestive and Liver Disease

P373 Real-file prospective experience with adalimumab in inducing remission in ulcerative colitis in Italian primary inflammatory bowel diseases centres

2017 · A. Tursi, L. Allegretta, et al. · Journal of Crohn s and Colitis

P.06.25 Infliximab and Adalimumab for Crohn's Disease in Real Life: Effectiveness, Safety and Ability in Obtaining Mucosal and Histological Healing

2014 · A. Tursi, W. Elisei, et al. · Digestive and Liver Disease

P.06.11 Histological Inflammation in Ulcerative Colitis in Deep Remission Under Treatment With Infliximab

2014 · A. Tursi, W. Elisei, et al. · Digestive and Liver Disease

Pp043-mon Toxicity of Radiotherapy on the Nutritional Status of Vitamins C and E in Breast Cancer

2012 · A. Matos, C. Franca, et al. · Clinical Nutrition Supplements

Plasmatic selenium levels before and after radiotherapy of prostate cancer; Niveis de selenio plasmatico antes e apos radioterapia no cancer de prostata

2011 · Callado França, A. Penna, et al. · Revista Brasileira de Cancerologia

P.1.191: Factors Influencing Mucosal Healing in Crohn's Disease During Infliximab Treatment in Clinical Practice

2011 · A. Tursi, W. Elisei, et al. · Digestive and Liver Disease

P.92 the Use of Adalimumab for the Treatment of Crohn's Disease in the Clinical Setting: an Italian Multi-center Study

2010 · A. Papa, G. Mocci, et al. · Digestive and Liver Disease

Works count: 18

Citation count: 120

H-index: 5

I10-index: 5